Immunity detection and titer testing are crucial for evaluating an individual's immune response to pathogens or vaccines. Immunity detection checks if immunity has been acquired, while titer testing measures specific antibodies in the blood. Titer tests indicate if enough antibodies are present for protection and if booster shots are needed. These tools are vital for monitoring immune status, guiding vaccination decisions, and informing healthcare providers in infectious disease management.
Sort by title | Sort by title | Sort by price | Sort by price
The CMV IgG Antibody Test is a blood test that detects the presence of IgG antibodies to cytomegalovirus (CMV). CMV is a common virus that can cause flu-like symptoms in healthy individuals but can be more serious in those with weakened immune systems. The presence of IgG antibodies suggests past exposure to CMV, helping healthcare providers diagnose infections. This test is commonly ordered for pregnant individuals or those at risk of CMV infection. A positive result indicates past CMV exposure, while a negative result may indicate no exposure or a recent infection without detectable IgG antibodies.
The diphtheria immunity test is a blood test used to measure antibodies against the diphtheria toxin to determine immunity. A blood sample is taken and sent for analysis. If low immunity is detected, a booster vaccine may be necessary. Regular vaccinations are recommended. The test is crucial in assessing immunity and the need for vaccination to prevent the spread of diphtheria.
Hepatitis A immunity testing, also known as hepatitis A antibody testing, is a blood test that detects antibodies to the hepatitis A virus, indicating past exposure or vaccination. It is recommended for at-risk individuals like healthcare workers and travelers. The test involves a blood sample and results are typically available within days. Depending on the results, vaccination may be advised.
The hepatitis A, B, and C antibodies confirmation panel is a blood test used to detect antibodies to these viruses in the body. It can determine past infections or vaccinations. The test helps diagnose and manage hepatitis and assess the need for vaccination. Consult a healthcare provider for concerns or risks of hepatitis infection.
The hepatitis B immunity status test, also known as the hepatitis B surface antibody test, measures antibody levels in the blood to determine immunity to the virus. The test helps healthcare providers assess the need for vaccination and further treatment for those at risk for hepatitis B. Results showing sufficient antibody levels indicate immunity, while lower levels may require additional testing or vaccination.
The hepatitis B surface antibody test measures antibodies in response to the virus, providing immunity. A quantitative test determines antibody concentration, important for protection against infection. High anti-HBs levels indicate immunity from vaccination or previous infection. Used to assess immunity in vaccinated individuals and determine need for booster doses. Results reported in IU/L and interpretation may vary.
The Hepatitis C Virus (HCV) Antibody Test is used to detect antibodies to HCV in the bloodstream. A positive result indicates past infection, while a negative result suggests no antibodies present. Further testing may be needed to determine current infection status, including viral load and liver function tests. A positive result doesn't always mean active infection, so consultation with a healthcare provider is recommended for further evaluation.
The IgE test measures IgE antibody levels in the blood, crucial for allergic reactions and often elevated in individuals with allergies or asthma. It helps diagnose allergies when symptoms are unclear and identifies specific allergens causing reactions, guiding treatment options. The test, used alongside medical history and examination, informs healthcare providers on recommending treatments such as allergen avoidance or medications.
A Lymphocyte Subset Panel is a blood test that measures the different types of white blood cells, specifically lymphocytes, to help diagnose and monitor immune disorders. The panel includes 7 tests that measure the number of different types of lymphocytes, including T-cells, B-cells, natural killer cells, and others. The results of the test can be used to diagnose immune disorders such as HIV/AIDS, chronic lymphocytic leukemia, or lymphoma, monitor treatment effectiveness, identify immune suppression or dysfunction, and detect abnormal immune cell populations. The test is typically ordered by a healthcare provider to investigate symptoms such as recurring infections, weakness or fatigue, swollen lymph nodes, fever, skin rash, joint pain, and weight loss.
The Measles Immunity Test (IgG) is a laboratory test that measures the level of measles-specific antibodies (IgG) in an individual's blood to determine if they have developed immunity to measles through vaccination or natural infection. The test works by collecting a blood sample, mixing it with a measles antigen, and measuring the amount of IgG antibodies bound to the antigen using an ELISA test. The results are interpreted as: negative- no immunity and at risk of infection, positive- immunity either through vaccination or natural infection, titers- indicates the level of IgG antibodies, with higher values indicating higher immunity. The advantages of this test are: it is non-invasive, requiring only a blood sample; accurate and reliable in detecting measles immunity; can identify individuals at risk of measles infection due to lack of immunity.
The MMR Immunity Profile Test is a blood test that checks for antibodies against measles, mumps, and rubella (MMR) viruses. The test measures the level of antibodies in your blood using one of two methods: serum titration or enzyme-linked immunosorbent assay (ELISA). The test results indicate whether you have immunity to MMR viruses and what type of immunity you have, with three possible results: immune, partially immune, or non-immune. The test is important for public health, as it helps identify individuals who are at risk of contracting MMR viruses and target vaccination efforts accordingly. It is also important for personal health, as it helps individuals determine whether they are immune to MMR viruses and need to receive vaccination or booster shots. Additionally, the test is important for pregnant women, healthcare workers, and individuals with weakened immune systems, as it can help them take precautions to avoid exposure to MMR viruses.
The Mumps IgG Immunity Test is a laboratory test that detects the presence of mumps IgG antibodies in the blood to determine if an individual has developed immunity to mumps. The test is typically performed as a blood test, where a sample of blood is collected from a vein in the arm. The results will indicate whether the individual has developed immunity, has not developed immunity, or the test is inconclusive. A positive result indicates that the individual has developed immunity to mumps and is likely to be protected against future infection. This can be important for prevention, public health, and vaccination purposes.
The Rubella Antibodies Test is a diagnostic tool to identify rubella virus antibodies in the blood. Two antibody types, IgG and IgM, are tested for. IgG signifies past immunity from infection or vaccination, while IgM indicates recent infection. The test is commonly included in prenatal screenings to assess rubella immunity and can confirm recent infections. Consulting a healthcare provider for result interpretation and appropriate next steps is crucial.
A Rubella IgG Immunity Test is a blood test used to determine if an individual has immunity to Rubella by measuring IgG antibodies in the blood. Rubella is a viral infection that can be harmful, especially to pregnant women. Testing is recommended for pregnant women, unvaccinated individuals, those with incomplete vaccine doses, and travelers to high-risk areas. The test involves drawing a blood sample, which is then analyzed in a laboratory for IgG antibodies against Rubella. Positive results indicate immunity, while negative results may require vaccination.
The Tetanus and Diphtheria titer test measures antibody levels in your blood to check immunity against Tetanus and Diphtheria. It is recommended for adults needing booster shots or at risk individuals. Results guide the need for a booster vaccine.
The tetanus antitoxoid titer test measures blood antibody levels to determine immunity to tetanus and the need for a booster vaccine. High titer levels provide protection, while low levels suggest the need for a vaccine. It is crucial to maintain tetanus immunity due to the bacteria's presence in soil, dust, and manure, potentially entering the body through cuts or wounds.
The Tuberculosis Gold Blood Test, also known as IGRA, is a blood test that detects Mycobacterium tuberculosis in the body, aiding in the diagnosis of TB infections. It is more specific than the tuberculin skin test and measures the immune response by detecting interferon-gamma release. Recommended for high-risk individuals, the test helps in appropriate treatment and management of TB infections.
The Varicella Zoster Virus (VZV) IgG titer test is a blood test that checks for antibodies to the varicella zoster virus, which causes chickenpox and shingles. A positive result shows past exposure and immunity, while a negative result indicates susceptibility. The test is used to assess immunity in high-risk individuals and confirm cases of chickenpox or shingles.
USLABTESTING